Co-morbid physical illness has been suggested to play an important role among the factors contributing to treatment resistance in patients with major depressive disorder. In the current study we compared the rate of physical co-morbidity, defined by ICD-10, among a large multicenter sample of 702 patients with major depressive disorder. A total of 356 of the participants were defined as treatment resistant depression (TRD) patients-having failed two or more adequate antidepressant trials. No significant difference was found between TRD and non-TRD participants in the prevalence of any ICD-10 category. This finding suggests that although physical conditions such as diabetes, thyroid dysfunction, hypertension, ischemic heart disease, and peptic diseases are often accompanied by co-morbid MOD, they do not necessarily have an impact on the course of MOD or the likelihood to respond to treatment. Marginally higher rates of co-morbid breast cancer, migraine and glaucoma were found among TRD participants. Possible explanations for these findings and their possible relation to TRD are discussed. (C) 2012 Elsevier B.V. and ECNP. All rights reserved.

Amital, D., Fostick, L., Silberman, A., Calati, R., Spindelegger, C., Serretti, A., et al. (2013). Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 23(8), 895-901 [10.1016/j.euroneuro.2012.09.002].

Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder

Calati R;
2013

Abstract

Co-morbid physical illness has been suggested to play an important role among the factors contributing to treatment resistance in patients with major depressive disorder. In the current study we compared the rate of physical co-morbidity, defined by ICD-10, among a large multicenter sample of 702 patients with major depressive disorder. A total of 356 of the participants were defined as treatment resistant depression (TRD) patients-having failed two or more adequate antidepressant trials. No significant difference was found between TRD and non-TRD participants in the prevalence of any ICD-10 category. This finding suggests that although physical conditions such as diabetes, thyroid dysfunction, hypertension, ischemic heart disease, and peptic diseases are often accompanied by co-morbid MOD, they do not necessarily have an impact on the course of MOD or the likelihood to respond to treatment. Marginally higher rates of co-morbid breast cancer, migraine and glaucoma were found among TRD participants. Possible explanations for these findings and their possible relation to TRD are discussed. (C) 2012 Elsevier B.V. and ECNP. All rights reserved.
Articolo in rivista - Articolo scientifico
Depression; Physical co-morbidity; Treatment resistance; Treatment response
English
2013
23
8
895
901
none
Amital, D., Fostick, L., Silberman, A., Calati, R., Spindelegger, C., Serretti, A., et al. (2013). Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 23(8), 895-901 [10.1016/j.euroneuro.2012.09.002].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/249250
Citazioni
  • Scopus 24
  • ???jsp.display-item.citation.isi??? 25
Social impact